Showing results (141-150 of 175) with videos related to
Sort By:
Pageof 18
Open Forum Infectious Diseases|June 10, 2025
Sequencing HIV Diagnostic Samples to Detect Genetic Clusters and Assess Sequence Coverage GapsCara J Broshkevitch, Shuntai Zhou, Annalea Greifinger, et al.Biorxiv : the Preprint Server for Biology|February 20, 2025
HIV-1 Rebound Virus Consists of a Small Number of Lineages That Entered the Reservoir Close to ART InitiationLynn Tyers, Matthew Moeser, Jean Ntuli, et al.The Journal of Infectious Diseases|July 15, 2020
Near Real-Time Identification of Recent Human Immunodeficiency Virus Transmissions, Transmitted Drug Resistance Mutations, and Transmission Networks by Multiplexed Primer ID-Next-Generation Sequencing in North CarolinaShuntai Zhou, Sabrina Sizemore, Matt Moeser, et al.Science Translational Medicine|October 11, 2019
The replication-competent HIV-1 latent reservoir is primarily established near the time of therapy initiationMelissa-Rose Abrahams, Sarah B Joseph, Nigel Garrett, et al.Virology|December 17, 2009
A rev1-vpu polymorphism unique to HIV-1 subtype A and C strains impairs envelope glycoprotein expression from rev-vpu-env cassettes and reduces virion infectivity in pseudotyping assaysMatthias H Kraus, Nicholas F Parrish, Katharina S Shaw, et al.Plos One|June 5, 2015
Ongoing HIV Transmission and the HIV Care Continuum in North CarolinaAnna B Cope, Kimberly A Powers, JoAnn D Kuruc, et al.IUBMB Life|July 18, 2002
Alphavirus replicon particles as candidate HIV vaccinesNancy L Davis, Ande West, Elizabeth Reap, et al.Nature Communications|March 1, 2019
Rationally designed carbohydrate-occluded epitopes elicit HIV-1 Env-specific antibodiesCheng Zhu, Elena Dukhovlinova, Olivia Council, et al.Clinical and Translational Science|January 25, 2019
Predicting Efavirenz Concentrations in the Brain Tissue of HIV-Infected Individuals and Exploring their Relationship to Neurocognitive ImpairmentNithya Srinivas, Sarah Beth Joseph, Kevin Robertson, et al.Plos One|December 7, 2013
Pre-clinical development of a recombinant, replication-competent adenovirus serotype 4 vector vaccine expressing HIV-1 envelope 1086 clade CJeff Alexander, Jason Mendy, Lo Vang, et al.Pageof 18